Abstract
BackgroundData regarding the association between red cell distribution width (RDW) values and mortality in patients with stable coronary artery disease are scarce. We aimed to investigate the link between mortality and RDW in patients with stable coronary artery disease undergoing percutaneous coronary intervention (PCI).MethodsWe analyzed 2550 consecutive patients with stable coronary artery disease who underwent PCI between 2007 and 2011 at our institution. The patients were divided into four groups according to RDW quartiles. The association between the RDW values and the outcomes was assessed using Cox proportional regression analysis after adjusting for clinical, echocardiographic, hemodynamic and laboratory data in the whole population and in subgroups stratified by gender, presence of diabetes, anemia or heart failure.ResultsIn the entire population, there was a stepwise relationship between RDW intervals and comorbidities. Patients with the highest RDW values were older and more often burdened with diabetes, heart failure and chronic kidney disease. There was an almost 4-fold increase in mortality during an average of 2.5 years of follow-up between the group of patients with RDW values lower than 13.1% (25th percentile) and the group with RDW values higher than 14.1% (75th percentile), (4.3% vs. 17.1%, p < 0.0001). After adjusting for the covariates, RDW remained significantly associated with mortality in the whole cohort (HR-1.23 [95% CI (1.13-1.35), p < 0.0001]) and in the subgroups stratified by gender, age (over and under 75 years), presence of anemia, diabetes, heart failure and chronic kidney disease.ConclusionHigher RDW values correspond to higher comorbidity burdens and higher mortality. RDW is an independent predictor of mortality in patients with stable coronary artery disease.
Highlights
Data regarding the association between red cell distribution width (RDW) values and mortality in patients with stable coronary artery disease are scarce
Red cell distribution width (RDW) was highly significantly associated with mortality in the entire cohort and in a subset of patients stratified by age, gender, anemia status, chronic kidney disease (CKD), diabetes and heart failure (Table 4)
Adding RDW to model based on clinical variables, ejection fraction hemodynamic data creatinine, and mean corpuscular volume (MCV) resulted significantly improved the model (p < 0.001) Harrell’s-C statistic increased only slightly from 0.76 to 0.77
Summary
Data regarding the association between red cell distribution width (RDW) values and mortality in patients with stable coronary artery disease are scarce. We aimed to investigate the link between mortality and RDW in patients with stable coronary artery disease undergoing percutaneous coronary intervention (PCI). Red cell distribution width (RDW) is a numerical measure of erythrocyte variability and heterogeneity (i.e., anisocytosis). In recent years there have been studies referring to patients with heart failure [2], with acute coronary syndromes [3] and unselected patients undergoing percutaneous coronary intervention (PCI) [4,5] and various noncardiological conditions [6,7,8]. We aimed to investigate the link between mortality and RDW in the wide spectrum of patients with stable coronary artery disease undergoing PCI with stent implantation over long term follow-up
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have